MyFinsight
Home
About
Contact
Back
Income Statement
Cadrenal Therapeutics, Inc. (CVKD)
source: myfinsight.com
Download
Download image
Interest and dividend
income
$67,004
Net loss and
comprehensive loss
-$3,667,287
Total other income
$67,004
Loss from operations
-$3,734,291
Total operating
expenses
$3,734,291
Depreciation expense
$401
General and
administrative expenses
$2,656,392
Research and development
expenses
$1,077,498
Back